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Deoxyribonucleotide pools are maintained at levels that support efficient and yet accurate DNA replication and repair. Rad53 is part
of a protein kinase regulatory cascade that, conceptually, promotes dNTP accumulation in four ways: (1) it activates the transcription of
ribonucleotide reductase subunits by inhibiting the Crt1 repressor; (2) it plays a role in relocalization of ribonucleotide reductase subunits
RNR2 and RNR4 from nucleus to cytoplasm; (3) it antagonizes the action of Sml1, a protein that binds and inhibits ribonucleotide
reductase; and (4) it blocks cell-cycle progression in response to DNA damage, thus preventing dNTP consumption through replication
forks. Although several lines of evidence support the above modes of Rad53 action, an effect of a rad53 mutation on dNTP levels has not
been directly demonstrated. In fact, in a previous study, a rad53-11 mutation did not result in lower dNTP levels in asynchronous cells or
in synchronized cells that entered the S-phase in the presence of the RNR inhibitor hydroxyurea. These anomalies prompted us to inves-
tigate whether the rad53-11 mutation affected dNTP levels in cells exposed to a DNA-damaging dose of ethylmethyl sulfonate (EMS).
Although dNTP levels increased by 2- to 3-fold in EMS treated wild-type cells, rad53-11 cells showed no such change. Thus, the results
indicate that Rad53 checkpoint function is not required for dNTP pool maintenance in normally growing cells, but is required for dNTP
pool expansion in cells exposed to DNA-damaging agents.
 2006 Elsevier Inc. All rights reserved.
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deoxyribonucleotide triphosphate levels during DNA syn-
thesis and repair. Yeast cells respond to DNA damage
and replication block by arresting the progression of the
cell cycle at specific points and by inducing the expression
of genes thought to facilitate DNA repair. These responses
are mediated by a kinase cascade that appears to be con-
served among eukaryotes. Two essential genes, MEC1
and RAD53, are central players in the kinase cascade that
leads to cell-cycle arrest at all the checkpoints and tran-
scriptional activation in response to DNA damage. Cells
with mutations in the Mec1 or Rad53 genes are defective
in both cell-cycle arrest and gene expression responses in0006-291X/$ - see front matter  2006 Elsevier Inc. All rights reserved.
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E-mail address: ahmetkoc@iyte.edu.tr (A. Koc).response to DNA damage, but retain their essential func-
tions for cell survival under normal conditions [1–5].
Among the best characterized transcriptional targets of
the Rad53 kinase cascade are the RNR genes, which
encode subunits of ribonucleotide reductase, the enzyme
that catalyzes the rate-limiting step in dNTP synthesis [1].
In addition to transcriptional induction of RNR genes,
the Rad53 pathway also induces RNR activity through
the removal of Sml1, an RNR inhibitor that binds to large
subunits and inhibits enzyme activity [6]. Lethality of
Rad53 null mutation is suppressed by overexpression of
genes encoding ribonucleotide reductase [3] or by deletion
of RNR inhibitor Sml1 [6]. Thus, it could be concluded
that essential function of the Rad53 pathway is to maintain
dNTP pools.
Although many studies have investigated the mecha-
nisms of RNR regulation, relatively few have determined
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Fig. 1. Deoxyribonucleotide triphosphates levels in wild-type (WT) and
rad53-11 yeast before and after EMS-induced DNA damage. WT
(MY377) and rad53-11 mutants cells (MY376) were grown in YPD at
30 C to a density of 107 cells/ml. Cultures were split, incubated with or
without EMS (0.01%) for 1 h at 30 C, and then harvested for dNTP pool
measurements. (A) dNTP pools of WT cells in the absence or presence of
EMS. (B) dNTP pools of rad53-11 cells in the absence or presence of
EMS. Error bars represent the range of duplicate determinations.
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dNTP levels. One exception is a study showing that sml1
mutants have levels of dNTPs that are 2.5-fold higher than
wild-type cells [6]. Given that Rad53 inhibits Sml1, we were
surprised that a checkpoint-deficient rad53-11 allele did not
result in lower dNTP levels in asynchronously growing cells
[7]. Loss of function mutations in Rad53 would be expected
to stimulate Sml1, inhibit RNR activity and lower dNTP
levels. Although mutation of Sml1 has been shown to
increase dNTP levels, it has never been established that
mutation of Rad53 has a reciprocal effect on dNTP levels.
Furthermore, Rad53 stimulates transcription of the genes
required for dNTP synthesis, including RNR1, 2, and 4
[1]. Thus, mutation of Rad53 would also be expected to
have a transcriptionally mediated inhibitory effect on
dNTP levels. To test these expectations, we determined
the levels of dNTP in wild-type and rad53-11 yeast that
were treated with EMS to induce DNA damage. While
EMS treatment led to a 2- to 3-fold increase in the size
of all four dNTP pools within wild-type cells, rad53-11
mutants did not exhibit increased dNTP pools which sug-
gests that the Rad53 pathway is required for dNTP accu-
mulation upon exposure to DNA damage.
Materials and methods
Yeast cells, growth and EMS treatment. Cells were grown in YPD
media. Wild-type strain MY377 (MAT-a ade2 ura3 leu2 trp1 his3 bar1)
and rad53-11 mutant strain MY376 (MAT-a ADE2 ura3 leu2 trp1 his3
rad53-11 pep4:URA3 bar1) have been previously described [7].
Ethylmethylsulfonate (EMS) mutagenesis was done as described by
Machado et al. [8].
dNTP pool measurements. Approximately 3 · 108 cells were harvested
and extracted as described by Muller [9]. Each precipitated sample was
resuspended in 200 ll of cold H2O and assayed for each of the four dNTPs
by the DNA polymerase-based enzymatic assay [10], which is based on the
incorporation of a limiting dNTP into an alternating co-polymer template
poly(dA–dT) or poly(dI–dC) by Klenow DNA polymerase in the presence
of an excess of 3H-labeled complementary dNTP.
Results
To assess the role of the Rad53 pathway in dNTP accu-
mulation, we first tested whether EMS treatment would
elevate the size of the dNTP pools in wild-type cells. Asyn-
chronously growing wild-type cells (MY377) were treated
with 0.01% EMS, a DNA alkylating agent, and levels of
all four dNTPs were measured. As shown in Fig. 1A, the
dNTP pools in untreated cells were 256 ± 8 pm/108 cells
for dTTP, 476 ± 44 pm/108 cells for dATP, 153 ± 8 pm/
108 cells for dCTP and 130 ± 8 pm/108 cells for dGTP.
After 1-h EMS treatment, the dNTP pools were
746 ± 20 pm/108 cells for dTTP, 476 ± 44 pm/108 cells
for dATP, 351 ± 4 pm/108 cells for dCTP and
256 ± 21 pm/108 cells for dGTP. Thus, EMS-induced
DNA damage led to a 2- to 3-fold increase in dNTP pool
sizes in wild-type cells.
We next considered whether DNA damage would have
an effect on the size of the dNTP pools in rad53-11mutants. As shown in Fig. 1B, the dNTP pools in untreat-
ed asynchronously growing rad53-11 mutants were
420 ± 8 pm/108 cells for dTTP, 167 ± 10 pm/108 cells for
dATP, 151 ± 1 pm/108 cells for dCTP and 123 ± 3 pm/
108 cells for dGTP. After 1-h EMS treatment, the dNTP
pools were 426 ± 9 pm/108 cells for dTTP, 182 ± 7 pm/
108 cells for dATP, 129 ± 3 pm/108 cells for dCTP, and
126 ± 2 pm/108 cells for dGTP. Unlike wild-type cells,
rad53-11 mutants were not able to elevate their dNTP
pools in response to EMS-induced DNA damage, which
suggested that an intact Rad53 pathway was required for
dNTP accumulation after DNA damage.Discussion
In yeast, the convergence of many different RNR regu-
latory mechanisms to the Rad53 pathway highlights the
role of the pathway in dNTP synthesis in response to
DNA damage. However, there has been no study showing
a direct relationship between the level of dNTPs and the
Rad53 pathway. Our study revealed that the Rad53 path-
way is necessary for dNTP accumulation in response to
DNA damage.
It has been shown that cell survival after DNA damage
is directly linked to elevated levels of dNTPs in yeast [11].
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ambiguous since neither logarithmically growing nor syn-
chronized cells show accumulation of dNTP pools after
DNA damage [12]. Our data are consistent with the idea
that cells accumulate dNTPs in response to DNA damage
as suggested by Chabes et al. [11]. Although the DNA
damage response and dNTP synthesis pathways of yeast
and mammals have significant similarities, it is neither clear
why mammalian cells do not show an increase in the sizes
of their dNTP pools nor how they perform the repair pro-
cess in the event of DNA damage.
Our dNTP pool measurements in wild-type and rad53-
11 mutant cells were consistent with previously published
results [7,13–15]. In one of our previous studies, similar
dNTP levels were observed for asynchronous rad53-11
cells, and mutants did not show any cell-cycle perturba-
tions when analysed by flow cytometry, which suggested
that rad53-11 cells operate under a normal cell-cycle pro-
gression. However, the magnitude of the increase in dNTP
levels in synchronized wild-type yeast as cells progressed
through the S-phase was more significant than that of syn-
chronized rad53-11 cells. This shows that the Rad53 path-
way plays a role in induction of dNTP synthesis during a
normal S-phase [7]. In spite of having slightly lower
amount of dNTPs, the normal cell-cycle progression of
rad53-11 cells also shows that the level of dNTPs is above
the threshold level required for efficient DNA synthesis
during a normal S-phase.
Normal transcriptional regulation of RNR is governed
by a cell-cycle-dependent mechanism exaggerated by cis-
acting-elements (MCB elements) which ensure expression
at the late G1-/S-phase of the cell cycle [1,16]. The
RAD53 gene also contains two similar cis-acting-elements
in its promoter that up-regulate its expression at late
G1-/S-phase [17]. Cell-cycle regulation of Rad53 mayDNA damage
Rad53
Sml1
NDPs
dNDPs dNTPs
DNA repair
RNR
Mec1
Cell cycle
progression
Crt1RNR subunit 
relocalization
Fig. 2. A model showing the role of the Rad53 pathway in dNTP
accumulation in response to DNA damage (intermediate players are not
shown). It is hypothesized that cessation of DNA replication, upregulation
of RNR via transcriptional induction, Sml1 inhibition and RNR subunit
relocalization lead to dNTP accumulation.be important for S-phase specific inhibition of Sml1 to
release RNR activity during a normal S-phase. But, in
response to DNA damage it probably shows its effect
through a combined mechanism involving RNR tran-
scriptional activation, Rnr2 and Rnr4 re-localization
and Sml1 inhibition which together may ensure that
the cells synthesize an adequate amount of dNTPs to
repair DNA damage (Fig. 2). We have previously shown
that when DNA replication is blocked by a dbf4 muta-
tion, cells hyper-accumulate dNTPs upon entry into the
S-phase [14]. Based on this observation, a possible expla-
nation of how wild-type cells accumulated dNTPs in
response to EMS treatment, while rad53-11 cells did
not, is that exposure to EMS triggers an S-phase specific
checkpoint which halts replication fork progression and
stops dNTP consumption during the S-phase in wild-type
cells but not in rad53-11 cells. Thus, further studies
should be performed to understand these Rad53-depen-
dent mechanisms and to determine to what extent they
play a role for increasing dNTP levels in response to
DNA damage.References
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